Sobi Shows Positive EMBRACE Data | US FDA Grants Breakthrough Tag to Sanofi

Probiotic Boosts Sleep | CBD Therapy Shows Early Promise

Tremfya Delivers Strong Crohn’s Data | Alebund Finishes Global Phase 3 Trial

Capricor to Present at 2026 MDA Conference | Neurent NEUROMARK Trial Positive

Novo Nordisk’s CagriSema bested by Lilly’s Zepbound in head-to-head trial.

FDA Grants Authorisation for Minder®, the First and Only Implantable Continuous

Sanofi Psoriasis Trial Falls Short | Focus Shifts to Combination Therapies

Novo Nordisk Boosts Access with ₹202/Day Ozempic & Wegovy

Everest Medicines Signs Deal with Corxel Pharmaceuticals for Cardamyst Nasal Spray

Hoth Therapeutics Reports Positive MASLD Data | POLY-ACS Trial Highlights Polypill Strategy

GSK Expands Pipeline with 35Pharma Acquisition

Lundbeck Completes Enrollment in Phase 3 MASCOT Trial Ahead of Schedule

EyePoint DURAVYU Clears Safety Review | REGENXBIO Shows Phase 3 Success

Arletta Pharma Reports Positive Phase II Results | Eli Lilly Ebglyss Shows 4-Year Control

BioVersys’ AlpE TB Study Published in NEJM | Merck Shares Positive Enflonsia RSV Data

AstraZeneca Tozorakimab Meets Phase III Endpoint in COPD Trial

Amydis Wins $2.5M National Institutes of Health Grant for TDP-43 Biomarker Research

Industry Leaders- Media coverage | Lifescience Intellipedia | Chemxpert Database | Clival Database

Roche Columvi Combo Delivers Sustained 3-Year Survival Benefit – Clinical News Update

Draig Begins Phase 2 for Depression | WHO Unveils New Bacterial Treatment Data– Clinical News Update

Myrtelle’s Canavan Trial Success | NeuroSense Marks Alzheimer’s Progress – Clinical News Update

Tzield sBLA Gets Priority Review | Endeavor Health in Landmark Live CTE Study

CPP Phase 3 Trial Positive | Edgewise Advances EDG-7500 in Hypertrophic Cardiomyopathy

AstraZeneca Hits Phase 3 Milestone | Skye Bioscience Unveils CBeyond Results– Clinical News Update

Ascletis Gets FDA OK for ASC30 Study | AZ’s Saphnelo Shows Strong Phase III SLE Data

$2M ALS Trial Support Announced | Ionis Wins Breakthrough Status for Zilganersen – Clinical News

Valneva Advances Zika Vaccine | Calico Earns FDA Orphan Drug – Clinical News Update Nod

ADC Therapeutics to Update on LOTIS-7 Trial – Clinical News Update

Functional Gut Clinic Launches Trials Unit | Pegrizeprument Gets Orphan Drug Status

Triveni Bio Starts Phase 2 | Imlifidase Succeeds in Phase 3 Kidney Trial – Clinical News Update

GC Biopharma Secures IND OK in Korea for COVID-19 mRNA Vaccine Trial

Recross Cardio Enrolls First Patient | Granata Bio Reports Strong Phase III GRACE Enrollment

Thermo Fisher Enrolls First Patient in PPD CorEvitas Alzheimer’s Registry

Sanofi Lunsekimig Hits Phase 2 Goals | Health Canada Clears Affinia Therapeutics Trial

AstraZeneca Tozorakimab Meets Phase III Endpoints in COPD Trials

Energenesis Highlights DFU Therapy at EWMA 2026 | Viking VK2735 Gains Momentum